GR3018105T3 - Antiviral purine derivatives and process for their preparation. - Google Patents
Antiviral purine derivatives and process for their preparation.Info
- Publication number
- GR3018105T3 GR3018105T3 GR950403221T GR950403221T GR3018105T3 GR 3018105 T3 GR3018105 T3 GR 3018105T3 GR 950403221 T GR950403221 T GR 950403221T GR 950403221 T GR950403221 T GR 950403221T GR 3018105 T3 GR3018105 T3 GR 3018105T3
- Authority
- GR
- Greece
- Prior art keywords
- hydrogen
- ch2oh
- preparation
- alkyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Sub-Exchange Stations And Push- Button Telephones (AREA)
- Jib Cranes (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Nonmetallic Welding Materials (AREA)
- General Factory Administration (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858530813A GB8530813D0 (en) | 1985-12-13 | 1985-12-13 | Compounds |
| GB868603228A GB8603228D0 (en) | 1986-02-10 | 1986-02-10 | Compounds |
| GB868620849A GB8620849D0 (en) | 1986-08-28 | 1986-08-28 | Compounds |
| GB868626041A GB8626041D0 (en) | 1986-10-31 | 1986-10-31 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3018105T3 true GR3018105T3 (en) | 1996-02-29 |
Family
ID=27449713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR950403221T GR3018105T3 (en) | 1985-12-13 | 1995-11-16 | Antiviral purine derivatives and process for their preparation. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0242482B1 (el) |
| JP (1) | JPH085886B2 (el) |
| KR (1) | KR940010033B1 (el) |
| AT (1) | ATE127466T1 (el) |
| AU (1) | AU599066B2 (el) |
| CA (1) | CA1296726C (el) |
| DE (1) | DE3650384T2 (el) |
| DK (1) | DK166823B1 (el) |
| ES (1) | ES2076139T3 (el) |
| FI (1) | FI85143C (el) |
| GR (1) | GR3018105T3 (el) |
| HU (1) | HU200461B (el) |
| IL (1) | IL80947A (el) |
| MA (1) | MA20828A1 (el) |
| MY (1) | MY101126A (el) |
| NO (1) | NO166226C (el) |
| NZ (1) | NZ218598A (el) |
| PL (3) | PL150841B1 (el) |
| PT (1) | PT83911B (el) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8602346D0 (en) * | 1986-01-30 | 1986-03-05 | Wellcome Found | Antiviral combinations |
| GB8712744D0 (en) * | 1987-05-30 | 1987-07-01 | Beecham Group Plc | Active compounds |
| GB8713695D0 (en) * | 1987-06-11 | 1987-07-15 | Beecham Group Plc | Process |
| US4965270A (en) * | 1987-05-30 | 1990-10-23 | Beecham Group P.L.C. | Purine derivatives |
| GB8724765D0 (en) * | 1987-10-22 | 1987-11-25 | Beecham Group Plc | Process |
| SE8801729D0 (sv) * | 1988-05-06 | 1988-05-06 | Astra Ab | Purine derivatives for use in therapy |
| EP0353955A3 (en) * | 1988-08-02 | 1991-08-14 | Beecham Group Plc | Novel compounds |
| DK135489D0 (da) * | 1989-03-20 | 1989-03-20 | Gea Farmaceutisk Fabrik As | Fremgangsmaade til fremstilling af 9-substituerede guaninderivater og mellemprodukter til brug ved fremgangsmaaden |
| GB8907173D0 (en) * | 1989-03-30 | 1989-05-10 | Beecham Group Plc | Novel compounds |
| GB8912043D0 (en) * | 1989-05-25 | 1989-07-12 | Beecham Group Plc | Novel compounds |
| GB8918827D0 (en) * | 1989-08-17 | 1989-09-27 | Beecham Group Plc | Novel compounds |
| US5252575A (en) * | 1989-08-17 | 1993-10-12 | Beecham Group P.L.C. | Antiviral purine derivatives with improved gastrointestinal absorption |
| GB9107896D0 (en) * | 1991-04-13 | 1991-05-29 | Smithkline Beecham Plc | Pharmaceuticals |
| JP2720681B2 (ja) * | 1992-01-06 | 1998-03-04 | 株式会社村田製作所 | 移動体の移動検出装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4347360A (en) * | 1980-09-16 | 1982-08-31 | Ens Bio Logicals Inc. | Ring open nucleoside analogues |
| DE3376326D1 (en) * | 1982-10-14 | 1988-05-26 | Wellcome Found | Antiviral purine derivatives |
| PT78769A (en) * | 1983-06-24 | 1984-07-01 | Merck & Co Inc | Process for preparing (s)-9-(2,3-dihydroxy-1-propoxymethyl)guanine and derivatives thereof useful as antiviral agents |
| ES8705889A1 (es) * | 1984-12-12 | 1987-06-01 | Syntex Inc | Un metodo para preparar eteres alcaximetilicos y esteres alcoximetilicos de derivados de guananina. |
-
1986
- 1986-12-10 MY MYPI86000187A patent/MY101126A/en unknown
- 1986-12-11 NO NO865014A patent/NO166226C/no unknown
- 1986-12-11 DE DE3650384T patent/DE3650384T2/de not_active Expired - Lifetime
- 1986-12-11 PT PT83911A patent/PT83911B/pt not_active IP Right Cessation
- 1986-12-11 DK DK595886A patent/DK166823B1/da not_active IP Right Cessation
- 1986-12-11 CA CA000525073A patent/CA1296726C/en not_active Expired - Fee Related
- 1986-12-11 PL PL1986262930A patent/PL150841B1/pl unknown
- 1986-12-11 AT AT86309667T patent/ATE127466T1/de not_active IP Right Cessation
- 1986-12-11 PL PL1986272032A patent/PL150926B1/pl unknown
- 1986-12-11 EP EP86309667A patent/EP0242482B1/en not_active Expired - Lifetime
- 1986-12-11 ES ES86309667T patent/ES2076139T3/es not_active Expired - Lifetime
- 1986-12-11 NZ NZ218598A patent/NZ218598A/xx unknown
- 1986-12-11 KR KR1019860010590A patent/KR940010033B1/ko not_active IP Right Cessation
- 1986-12-11 AU AU66443/86A patent/AU599066B2/en not_active Ceased
- 1986-12-11 PL PL1986272031A patent/PL150925B1/pl unknown
- 1986-12-11 IL IL80947A patent/IL80947A/xx not_active IP Right Cessation
- 1986-12-12 FI FI865075A patent/FI85143C/fi not_active IP Right Cessation
- 1986-12-12 JP JP61295096A patent/JPH085886B2/ja not_active Expired - Lifetime
- 1986-12-12 MA MA21060A patent/MA20828A1/fr unknown
- 1986-12-12 HU HU865196A patent/HU200461B/hu not_active IP Right Cessation
-
1995
- 1995-11-16 GR GR950403221T patent/GR3018105T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3018105T3 (en) | Antiviral purine derivatives and process for their preparation. | |
| ES2057016T3 (es) | Compuestos de acido 3-pirrolidiniltio-1-azabiciclo (3.2.0) hept-2-eno-2-carboxilico. | |
| DE3370585D1 (en) | Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation | |
| PL276046A1 (en) | Method for manufacturing new derivatives of purine | |
| EP0446921A3 (en) | Optically active alkylene-dioxybenzene derivatives and their use in therapy | |
| ES8800194A1 (es) | Procedimiento para preparar eteres 1,3-dioxano | |
| EP0177728A3 (en) | Arphamenine derivatives, a process for their preparation and their use as medicament | |
| JO1346B1 (en) | The salts of the anti-malarial compounds Phenantrine Methanol |